1.Solitary myeloma with massive extracellular crystalline structures: a case report.
Yong Gu KIM ; Ki Hwa YANG ; Seok Jin GANG ; Byoung Kee KIM ; Sun Moo KIM
Journal of Korean Medical Science 1991;6(2):165-171
We describe a case of solitary myeloma showing cystic change filled with massive crystalline structures in a 54-year-old woman. A bone X-ray showed a solitary cystic osteolytic lesion in the right iliac bone. Serum and urine protein electrophoresis showed no demonstrable M-protein, and bone-marrow aspirates did not show any myeloma cells. Histologic examination of the tumor revealed aggregation of plasma cells with massive extracellular infiltration of the rhomboid-shaped crystalline structures. In immunoperoxidase staining, both these crystalline structures and the cytoplasms of the myeloma cells demonstrated a positive reaction for lambda light chain. By electron microscope, the large extracellular crystalline structures were observed, and we found unique rhomboid or rectangular-shaped crystalline structures in the cytoplasms of the myeloma cells.
Bone Neoplasms/immunology/*ultrastructure
;
Crystallization
;
Extracellular Space/immunology
;
Female
;
Humans
;
Immunoglobulin lambda-Chains/ultrastructure
;
Microscopy, Electron
;
Middle Aged
;
Plasmacytoma/immunology/*ultrastructure
2.Effect of TSP-2 antibody against a single epitope of mouse Toll-like receptor 2 extracellular domain on zymosan A-induced peritonitis in mice.
Cui-lan YANG ; Wen-zhong ZHAO ; En-ping HUANG ; Shen-qiu LUO
Journal of Southern Medical University 2009;29(8):1521-1524
OBJECTIVETo observe the effect of the antibody TSP-2 against a single epitope of mouse Toll-like receptor 2 extracellular domain (mTLR2ECD) on the inflammation in mice with zymosan A-induced peritonitis.
METHODSIn mice with peritonitis induced by intraperitoneal injection of zymosan A, pretreatments with PBS, normal rabbit IgG and TSP-2 antibody at two different doses (2.5 and 5.0 mg/kg) were administered via the tail vein. Six hours after intraperitoneal injection of zymosan A, Evans blue was injected through the tail vein, and the frequency of writhing of the mice within 20 min were recorded. The mice were then sacrificed for peritoneal lavage, and the lavage fluid was collected to assess the exudation of Evans blue in the supernatant. The peritoneal leukocyte count, mast cell degranulation and release of such inflammatory mediators as platelet activating factor (PAF) and tumor necrosis factor-alpha (TNFalpha) in the lavage fluid were observed by cell counting, specific cell staining, immunohistochemistry and enzyme-linked immunosorbent assay (ELISA).
RESULTSCompared with PBS or rabbit IgG groups, TSP-2 treatment resulted in significantly reduced writhing response of the mice and lowered Evans blue exudation and leukocyte count in the peritoneal lavage, with also decreased degranulation of the mast cells induced by C48/80.
CONCLUSIONTSP-2 antibody against a single epitope of mTLR2ECD inhibits the inflammatory response in mice with zymosan A-induced peritonitis.
Animals ; Antibodies ; immunology ; Behavior, Animal ; Epitopes ; immunology ; Extracellular Space ; Female ; Leukocyte Count ; Mast Cells ; immunology ; Mice ; Peritoneal Lavage ; Peritonitis ; chemically induced ; immunology ; Protein Structure, Tertiary ; Toll-Like Receptor 2 ; chemistry ; immunology ; Zymosan ; pharmacology